CDH VGC
Beijing, Beijingcdhfund.com
Overview
CDH VGC is the venture and growth capital (VGC) arm of CDH Investments, a Chinese alternative asset management firm. Founded in 2015, CDH VGC's mission is to invest in technological innovation to drive value creation with social impact. Its primary investment areas include healthcare, artificial intelligence & technology, consumer, and enterprise solutions. The firm combines a venture capital approach to assess growth potential with a growth equity approach to conduct in-depth research and mitigate risk. CDH VGC has invested in approximately 90 companies.
Portfolio Companies
21
Website
cdhfund.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Syneron Bio | Mar 2026 | Series B | Lead |
| Syneron Bio | Mar 2026 | Series B | Lead |
| AIsphere Technology | Mar 2026 | Series C | Lead |
| Robot Era | Mar 2026 | Strategic | Co-investor |
| Shanghai Leadingtac Pharmaceutical Co., Ltd. | Dec 2025 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
